Hemophilia

Haemophilia is a rare genetic bleeding disorder in which the body doesn't make enough clotting factors, which makes the blood clot improperly. This causes extended bleeding—even from little cuts. Haemophilia B (factor IX deficiency) and Haemophilia A (factor VIII deficit) are the most often occurring forms. Though women can be carriers, it mostly affects men since it is an X-linked recessive condition.
In severe cases, haemophilia can lead to life-threatening internal bleeding. Signs of this condition include getting too many bruises, bleeding into muscles and joints without any cause, and bleeding nonstop after injuries or procedures. Blood tests measuring clotting factor levels provide diagnoses.
Typically, the treatment involves injecting the absent clotting factor into the bloodstream through replacement therapy. Aiming for long-term answers, advanced treatments consist of gene therapy and recombinant clotting factors. Patients are urged to take care to avoid injuries and to stay away from contact sports.
Early diagnosis and appropriate treatment can enable people with haemophilia to lead normal lives even though there is no permanent cure. Regular medical treatment, physiotherapy, and clotting factor injections significantly reduce issues, thereby improving overall quality of life. As medical research continues to progress, future medicines for haemophilia may offer improved control and potential remedies.